US2008096247A1PendingUtilityA1

Nucleic acids encoding duramycin

Assignee: MOLICHEM MEDICINES INCPriority: Oct 10, 2002Filed: Apr 3, 2007Published: Apr 24, 2008
Est. expiryOct 10, 2022(expired)· nominal 20-yr term from priority
C07K 14/36A61K 38/00C12P 21/02
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Nucleic acids encoding preduramycin and produramycin are described, along with recombinant nucleic acids host cells containing the same and methods of use thereof, such as for the manufacture of the lantibiotic duramycin.

Claims

exact text as granted — not AI-modified
1 . An isolated nucleic acid selected from the group consisting of: 
 (a) a nucleic acid according to SEQ ID NO: 2 encoding preduramycin;    (b) a nucleic acid according to SEQ ID NO: 4 encoding produramycin;    (c) nucleic acids that are at least 95 percent identical in sequence to nucleic acids of (a) or (b) above and which encode preduramycin or produramycin;    (d) nucleic acids that differ from the nucleic acids of (a), (b), or (c) above due to the degeneracy of the genetic code, and which encode a preduramycin or produramycin encoded by a nucleic acid of (a), (b), or (c) above.    
     
     
         2 . The nucleic acid according to  claim 1 , wherein said nucleic acid is a DNA.  
     
     
         3 . The nucleic acid according to  claim 1  having a sequence according to SEQ ID NO: 2.  
     
     
         4 . The nucleic acid according to  claim 1  having a sequence according to SEQ ID NO:4.  
     
     
         5 . A recombinant nucleic acid comprising a nucleic acid according to  claim 1  operatively associated with a promoter.  
     
     
         6 . A vector comprising a recombinant nucleic acid according to  claim 5 .  
     
     
         7 . The vector of  claim 6 , wherein said vector is a plasmid.  
     
     
         8 . A recombinant cell comprising a heterologous nucleic acid according to  claim 1  and capable of expressing the encoded preduramycin or produramycin.  
     
     
         9 . The recombinant cell of  claim 8 , wherein said host cell is a gram positive bacteria.  
     
     
         10 . The recombinant cell of  claim 8 , wherein said cell is selected from the group consisting of genus  Bacillus , genus  Streptomyces  and genus  Streptococcus.    
     
     
         11 . A method of making preduramycin, produramycin or duramycin, comprising: 
 culturing a host cell according to  claim 8  under conditions which the encoded preduramycin or produramycin is expressed; and then    collecting preduramycin, produramycin or duramycin from said cultured host cells.    
     
     
         12 . The method of  claim 11 , wherein said host cell is a gram positive bacteria.  
     
     
         13 . The method of  claim 11 , wherein said host cell is selected from the group consisting of genus  Bacillus , genus  Streptomyces  and genus  Streptococcus.    
     
     
         14 . The method of  claim 11 , wherein said culturing step is carried out under conditions in which duramycin is produced by said host cell; and wherein said collecting step comprises collecting duramycin from said cultured host cells.

Join the waitlist — get patent alerts

Track US2008096247A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.